Sources: 12Gene Ontology See all sources |
Cellular components related to chondrodysplasia according to GeneDecks:| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | peroxisomal matrix | GO:005782 | 10.3 | CAT, HSD17B4, GNPAT, SCP2, PHYH, ACAA1 | | 2 | integral to peroxisomal membrane | GO:005779 | 10.1 | PEX3, PEX26, PEX2, PEX16, PEX13, PEX12 | | 3 | peroxisomal membrane | GO:005778 | 9.6 | PEX6, PEX5, PEX3, PEX2, PEX19, PEX16 | | 4 | proteinaceous extracellular matrix | GO:005578 | 9.6 | ACAN, COMP, MATN3, MATN1, FMOD, BGN | | 5 | peroxisome | GO:005777 | 9.5 | PEX1, SLC25A17, PMVK, AGXT, AGPS, ACOX1 | | 6 | lysosomal lumen | GO:043202 | 9.2 | ACAN, HSPG2, ARSB, ARSA, FMOD, BGN | | 7 | endoplasmic reticulum lumen | GO:005788 | 9.0 | COL8A1, COL11A1, COL2A1, COL9A1, STS, SLC27A2 | | 8 | extracellular matrix | GO:031012 | 8.5 | HAPLN1, ACAN, COMP, COL8A1, COL1A1, HSPG2 | | 9 | Golgi apparatus | GO:005794 | 7.6 | PTHLH, CREB3, CRELD2, PHEX, STS, PEX5 |
Biological processes related to chondrodysplasia according to GeneDecks: (show all 42)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | activation of protein kinase A activity | GO:034199 | 10.7 | ADCY1, ADCY3, ADCY6, ADCY8, ADCY2, ADCY4 | | 2 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway | GO:007193 | 10.7 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 3 | cellular response to glucagon stimulus | GO:071377 | 10.7 | ADCY3, ADCY6, ADCY8, ADCY2, ADCY4, ADCY5 | | 4 | cAMP biosynthetic process | GO:006171 | 10.7 | ADCY1, ADCY6, ADCY2, ADCY4 | | 5 | water transport | GO:006833 | 10.7 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 6 | ether lipid biosynthetic process | GO:008611 | 10.7 | PEX7, AGPS, GNPAT | | 7 | unsaturated fatty acid metabolic process | GO:033559 | 10.7 | HSD17B4, ACAA1, ACOX1, SCP2 | | 8 | activation of phospholipase C activity | GO:007202 | 10.7 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 9 | alpha-linolenic acid metabolic process | GO:036109 | 10.7 | SCP2, HSD17B4, ACAA1, ACOX1 | | 10 | fatty acid beta-oxidation using acyl-CoA oxidase | GO:033540 | 10.7 | ACOX1, SCP2, HSD17B4, ACAA1 | | 11 | energy reserve metabolic process | GO:006112 | 10.6 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 12 | protein import into peroxisome membrane | GO:045046 | 10.6 | PEX5, PEX3, PEX26, PEX19, PEX16 | | 13 | epidermal growth factor receptor signaling pathway | GO:007173 | 10.6 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 14 | peroxisome membrane biogenesis | GO:016557 | 10.6 | PEX3, PEX19, PEX16 | | 15 | adenylate cyclase-activating G-protein coupled receptor signaling pathway | GO:007189 | 10.6 | ADCY6, ADCY8, ADCY2, ADCY4, ADCY5, ADCY7 | | 16 | nerve growth factor receptor signaling pathway | GO:048011 | 10.6 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 17 | protein import into peroxisome matrix, translocation | GO:016561 | 10.5 | PEX14, PEX5, PEX6 | | 18 | protein targeting to peroxisome | GO:006625 | 10.5 | PEX6, PEX5, PEX19, PEX16, PEX12, PEX1 | | 19 | protein import into peroxisome matrix | GO:016558 | 10.5 | PEX5, PEX7, PEX26, PEX2, PEX1, PEX10 | | 20 | intracellular signal transduction | GO:035556 | 10.5 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 21 | transmembrane transport | GO:055085 | 10.5 | ADCY9, ADCY7, ADCY5, ADCY4, ADCY2, ADCY8 | | 22 | peroxisome organization | GO:007031 | 10.4 | PEX1, PEX10, PEX12, PEX14, PEX16, PEX19 | | 23 | fatty acid alpha-oxidation | GO:001561 | 10.4 | HACL1, PEX13, SLC27A2, SLC25A17, PHYH | | 24 | endochondral ossification | GO:001958 | 10.3 | PEX7, COL2A1, COL1A1, PTHLH, IMPAD1, FGFR3 | | 25 | synaptic transmission | GO:007268 | 10.3 | ADCY7, ADCY5, ADCY4, ADCY2, ADCY8, ADCY6 | | 26 | bile acid biosynthetic process | GO:006699 | 10.3 | SCP2, HSD17B4, SLC27A2, PEX2 | | 27 | chondrocyte differentiation | GO:002062 | 10.2 | COL9A1, COL2A1, PTH1R, FGFR3, FGFR1 | | 28 | fatty acid beta-oxidation | GO:006635 | 10.2 | HADHB, HSD17B4, ACAA1, ACAA2, SLC25A17, SLC27A2 | | 29 | cholesterol biosynthetic process | GO:006695 | 10.2 | EBP, PMVK, ACAA2, MVK | | 30 | glycosphingolipid metabolic process | GO:006687 | 10.1 | STS, SMPD3, SUMF1, ARSB, ARSA, ARSE | | 31 | sphingolipid metabolic process | GO:006665 | 10.1 | STS, SMPD3, SUMF1, ARSB, ARSA, ARSE | | 32 | post-translational protein modification | GO:043687 | 10.1 | STS, SUMF1, ARSB, ARSA, ARSE, ARSH | | 33 | very long-chain fatty acid metabolic process | GO:000038 | 10.0 | PEX5, ACOX1, ACAA1 | | 34 | phospholipid metabolic process | GO:006644 | 10.0 | HADHB, STS, SMPD3, SUMF1, GNPAT, ARSB | | 35 | bile acid metabolic process | GO:008206 | 10.0 | SCP2, HSD17B4, ACAA1, SLC27A2 | | 36 | chondroitin sulfate metabolic process | GO:030204 | 9.9 | HSPG2, IMPAD1, ARSB, CHST3, BGN | | 37 | fibroblast growth factor receptor signaling pathway | GO:008543 | 9.5 | ADCY2, ADCY4, ADCY5, ADCY7, ADCY9, ADCY8 | | 38 | positive regulation of phospholipase activity | GO:010518 | 9.5 | FGFR1, FGFR2, FGFR3 | | 39 | cellular lipid metabolic process | GO:044255 | 9.5 | AGPS, SLC25A17, SLC27A2, HACL1, HADHB, ACOX1 | | 40 | glycosaminoglycan metabolic process | GO:030203 | 9.4 | ACAN, HSPG2, ARSB, FMOD, CHST3, BGN | | 41 | skeletal system development | GO:001501 | 9.0 | COL10A1, COL1A1, COMP, COL2A1, PHEX, SHOX | | 42 | small molecule metabolic process | GO:044281 | 7.3 | BGN, HSD17B4, HSPG2, CAT, SUMF1, SMPD3 |
Molecular functions related to chondrodysplasia according to GeneDecks: (show all 11)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | adenylate cyclase activity | GO:004016 | 10.6 | ADCY3, ADCY9, ADCY7, ADCY4, ADCY2, ADCY8 | | 2 | calcium- and calmodulin-responsive adenylate cyclase activity | GO:008294 | 10.5 | ADCY5, ADCY2, ADCY8, ADCY6, ADCY1 | | 3 | arylsulfatase activity | GO:004065 | 10.3 | ARSB, ARSA, ARSE, ARSH, ARSF, ARSD | | 4 | acetyl-CoA C-acyltransferase activity | GO:003988 | 10.2 | ACAA1, ACAA2, HADHB | | 5 | receptor binding | GO:005102 | 9.9 | HACL1, ADCY6, PEX14, SLC27A2, AGXT, ACOX1 | | 6 | protein C-terminus binding | GO:008022 | 9.8 | PEX6, PEX5, PEX26, PEX16, PEX12, PEX10 | | 7 | extracellular matrix structural constituent | GO:005201 | 9.5 | ACAN, COL11A1, COMP, COL1A1, MATN3, MATN1 | | 8 | fibroblast growth factor-activated receptor activity | GO:005007 | 9.1 | FGFR3, FGFR2, FGFR1 | | 9 | metal ion binding | GO:046872 | 8.7 | ACAN, STS, ADCY1, ADCY3, ADCY6, ADCY8 | | 10 | ATP binding | GO:005524 | 8.2 | ADCY1, ADCY3, ADCY6, ADCY8, ADCY2, ADCY4 | | 11 | protein binding | GO:005515 | 4.0 | PEX13, PEX12, PEX10, PEX1, SLC25A17, STAT1 |
|